Translational Research in Methamphetamine Addiction Conference

描述（由申请人提供）：甲基苯丙胺成瘾在美国构成了一个严重且日益严重的药物滥用问题。到目前为止，还没有一个全国性的会议专门讨论甲基苯丙胺成瘾的基础和临床神经生物学。拟议的甲基苯丙胺成瘾转化研究会议计划于2010年7月举行，由两个NIDA支持的甲基苯丙胺研究中心共同主办：南卡罗来纳州医科大学成瘾转化研究中心和洛杉矶加州大学成瘾转化研究中心。这次会议将有广泛的吸引力成瘾研究人员，并将提供一个催化剂的研究互动为中心的基础和临床神经生物学的甲基苯丙胺滥用和依赖。会议的主题和组织形式将允许在对甲基苯丙胺成瘾的全面探索至关重要的领域的专业知识的交叉施肥，包括药理学，神经生物学，动物模型，临床评估，脑成像和新型治疗。本次会议的基础和临床研究人员的结合将允许独特的跨学科水平的沟通，并鼓励未来出现新的研究，培训和治疗机会。临床前报告将与临床报告紧密并列，从而促进将不同研究方法中的发现统一到对甲基苯丙胺成瘾的临床神经生物学基础的一致理解中。此外，年轻的研究人员将有很好的机会在会议上与来自全国各地的主要甲基苯丙胺研究人员互动。会议的主题整合将侧重于研究活动的多个方面，目标是在甲基苯丙胺成瘾，功能障碍和治疗领域提供翻译覆盖。因此，这次会议将是第一次提供一个关于甲基苯丙胺成瘾的论坛，该论坛显然与NIH路线图倡议保持一致。 公共卫生相关性：拟议的甲基苯丙胺成瘾转化研究会议计划于2010年7月举行，由MUSC成瘾转化研究中心和UCLA成瘾转化研究中心共同赞助。会议将包括在临床前和临床水平上对甲基苯丙胺成瘾的全面探索。会议的主题整合将为成瘾研究人员提供一个独特的论坛，介绍甲基苯丙胺成瘾的最新研究结果。

DESCRIPTION (provided by applicant): Methamphetamine addiction constitutes a serious and growing drug abuse problem in the United States. To date, there has not been a national conference devoted to the basic and clinical neurobiology of methamphetamine addiction. The proposed Translational Research in Methamphetamine Addiction conference is planned for July of 2010 and is co-sponsored by two NIDA-supported methamphetamine research centers: the Translational Research in Addiction Center at the Medical University of South Carolina and the Center for Translational Research of Addiction at the University of California, Los Angeles. This conference will have broad appeal to addiction researchers and will provide a catalyst for research interactions centered on the basic and clinical neurobiology of methamphetamine abuse and dependence. The topics and organizational format of the meeting will allow cross fertilization of expertise in areas that are critical to a comprehensive exploration of methamphetamine addiction, including pharmacology, neurobiology, animal models, clinical assessment, brain imaging, and novel treatment. The combination of basic and clinical researchers at this conference will allow unique interdisciplinary levels of communication and encourage the future emergence of new research, training, and treatment opportunities. The preclinical presentations will juxtapose closely with the clinical presentations and thereby facilitate the capacity to unite discoveries emerging from different research approaches into a coherent understanding of the clinical neurobiological basis of methamphetamine addiction. Furthermore, young investigators will have excellent opportunities at the conference to interact with leading methamphetamine researchers from around the country. The thematic integration of the conference will focus multiple dimensions of research activity with the goal of providing translational coverage in the field of methamphetamine addiction, dysfunction, and treatments. As such, the conference will be the first of its kind to provide a forum on methamphetamine addiction that is clearly aligned with the NIH Roadmap Initiative. PUBLIC HEALTH RELEVANCE: The proposed Translational Research in Methamphetamine Addiction conference is planned for July of 2010 and is co-sponsored by the MUSC Translational Research in Addiction Center and the UCLA Center for Translational Research of Addiction. The conference will include a comprehensive exploration of methamphetamine addiction at the preclinical and clinical levels. The thematic integration of the conference will offer addiction researchers a unique forum on current findings in methamphetamine addiction.